- Home
- KD vs CRNX Comparison
KD vs CRNX Comparison
Compare KD & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KD
- CRNX
- Stock Information
- Founded
- KD 2020
- CRNX 2008
- Country
- KD United States
- CRNX United States
- Employees
- KD N/A
- CRNX N/A
- Industry
- KD EDP Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- KD Technology
- CRNX Health Care
- Exchange
- KD Nasdaq
- CRNX Nasdaq
- Market Cap
- KD 5.3B
- CRNX 5.2B
- IPO Year
- KD N/A
- CRNX 2018
- Fundamental
- Price
- KD $35.39
- CRNX $55.37
- Analyst Decision
- KD Strong Buy
- CRNX Strong Buy
- Analyst Count
- KD 5
- CRNX 10
- Target Price
- KD $34.40
- CRNX $74.40
- AVG Volume (30 Days)
- KD 2.4M
- CRNX 594.1K
- Earning Date
- KD 02-04-2025
- CRNX 11-12-2024
- Dividend Yield
- KD N/A
- CRNX N/A
- EPS Growth
- KD N/A
- CRNX N/A
- EPS
- KD N/A
- CRNX N/A
- Revenue
- KD $15,299,000,000.00
- CRNX $1,038,999.00
- Revenue This Year
- KD N/A
- CRNX N/A
- Revenue Next Year
- KD $1.41
- CRNX $195.21
- P/E Ratio
- KD N/A
- CRNX N/A
- Revenue Growth
- KD N/A
- CRNX N/A
- 52 Week Low
- KD $19.19
- CRNX $33.67
- 52 Week High
- KD $36.43
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- KD 73.58
- CRNX 46.30
- Support Level
- KD $35.21
- CRNX $52.85
- Resistance Level
- KD $36.43
- CRNX $60.34
- Average True Range (ATR)
- KD 0.81
- CRNX 2.45
- MACD
- KD -0.19
- CRNX -0.33
- Stochastic Oscillator
- KD 60.31
- CRNX 33.64
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.